Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1958 (LINC01958) is a member of the **long intergenic non-coding RNA (lincRNA)** family, which are defined as RNA transcripts greater than 200 nucleotides in length that do not overlap protein-coding genes and do not encode proteins[1][7]. LINC01958, like other lincRNAs, is thought to play a regulatory role in gene expression at the transcriptional or chromatin level, although its specific biological functions and disease associations have not been clearly established[1][5]. There are no current data to indicate that LINC01958 is directly druggable or currently used as a therapeutic target or biomarker. Research on other lincRNAs suggests they may participate in diverse processes such as cell cycle regulation, apoptosis, and tumor progression, but these functions have not been demonstrated specifically for LINC01958[7][2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1958 (LINC01958).